Franklin Resources
ADVM

Franklin Resources’s Adverum Biotechnologies ADVM Stock Holding History

Franklin Resources’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,760,056
Closed -$7.69M – 3027
2025
Q1 		$7.69M Hold
1,760,056
– – ﹤0.01% 1187
2024
Q4 		$8.22M Hold
1,760,056
– – ﹤0.01% 1184
2024
Q3 		$13.6M Buy
1,760,056
+4
+0% +$29 ﹤0.01% 1010
2024
Q2 		$12.1M Buy
1,760,052
+1,084,377
+160% +$10.1M ﹤0.01% 1014
2024
Q1 		$9.55M Buy
+675,675
New +$10.3M ﹤0.01% 1096
2015
Q1 		– Sell
-16,630
Closed -$8.98M – 1579
2014
Q4 		$8.98M Buy
16,630
+5,000
+43% +$1.93M ﹤0.01% 1068
2014
Q3 		$3.98M Buy
+11,630
New +$3.46M ﹤0.01% 1223

Other funds holding ADVM

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $201M AUM 34.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources's ADVM Position: Q2 2025 in Review

Franklin Resources sold out of Adverum Biotechnologies (ADVM) in Q2 2025, closing a stake of 1,760,056 shares — an estimated $7.69M sold.

Franklin Resources first reported a position in ADVM in Q3 2014 and held it in 7 quarters. The position peaked at $13.6M in Q3 2024. 58 funds tracked by Wall St. Rank hold ADVM as of Q2 2025.

  • Franklin Resources reported no remaining Adverum Biotechnologies position as of Q2 2025 after selling out during the quarter.
  • Franklin Resources sold 1,760,056 Adverum Biotechnologies shares in Q2 2025, an estimated $7.69M.
  • Franklin Resources first reported a position in Adverum Biotechnologies in Q3 2014 and held it in 7 quarters.
  • Franklin Resources's Adverum Biotechnologies position peaked at $13.6M in Q3 2024.
  • 58 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2025.

Based on Franklin Resources's 13F filing for Q2 2025, filed 12 Aug 2025.